PURE Bioscience, Inc. (OTCMKTS:PURE – Get Free Report)’s share price passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.07 and traded as high as $0.08. PURE Bioscience shares last traded at $0.08, with a volume of 58,070 shares traded.
PURE Bioscience Trading Up 19.4 %
The company has a market capitalization of $8.95 million, a PE ratio of -1.33 and a beta of 0.07. The stock’s 50-day moving average is $0.07 and its two-hundred day moving average is $0.07.
PURE Bioscience Company Profile
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Read More
- Five stocks we like better than PURE Bioscience
- Stock Analyst Ratings and Canadian Analyst Ratings
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- What Investors Need to Know About Upcoming IPOs
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
